BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37104141)

  • 1. Using Brain Tumor MRI Structured Reporting to Quantify the Impact of Imaging on Brain Tumor Boards.
    Abidi SA; Hoch MJ; Hu R; Sadigh G; Voloschin A; Olson JJ; Shu HG; Neill SG; Weinberg BD
    Tomography; 2023 Apr; 9(2):859-870. PubMed ID: 37104141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interrater reliability of Brain Tumor Reporting and Data System (BT-RADS) in the follow up of adult primary brain tumors: a single institution experience in Italy.
    Parillo M; Mallio CA; Pileri M; Dirawe D; Romano A; Bozzao A; Weinberg B; Quattrocchi CC
    Quant Imaging Med Surg; 2023 Nov; 13(11):7423-7431. PubMed ID: 37969622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A brain tumor reporting and data system to optimize imaging surveillance and prognostication in high-grade gliomas.
    Kim S; Hoch MJ; Peng L; Somasundaram A; Chen Z; Weinberg BD
    J Neuroimaging; 2022 Nov; 32(6):1185-1192. PubMed ID: 36045502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External validation of the Brain Tumour Reporting and Data System (BT-RADS) in the multidisciplinary managementof post-treatment gliomas.
    Trivedi KH; Guha A; Thakur M; Mahajan A; Bhole P; Gupta T
    Pol J Radiol; 2024; 89():e148-e155. PubMed ID: 38550961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interrater Agreement of BT-RADS for Evaluation of Follow-Up MRI in Treated Primary Brain Tumor Patients.
    Essien M; Cooper ME; Gore A; Min TL; Risk BB; Sadigh G; Hu R; Hoch MJ; Weinberg BD
    AJNR Am J Neuroradiol; 2024 Apr; ():. PubMed ID: 38684320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Longitudinal Imaging Tracker (BrICS-LIT):A Cloud Platform for Monitoring Treatment Response in Glioblastoma Patients.
    Ramesh K; Gurbani SS; Mellon EA; Huang V; Goryawala M; Barker PB; Kleinberg L; Shu HG; Shim H; Weinberg BD
    Tomography; 2020 Jun; 6(2):93-100. PubMed ID: 32548285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Institutional Implementation of a Structured Reporting System: Our Experience with the Brain Tumor Reporting and Data System.
    Gore A; Hoch MJ; Shu HG; Olson JJ; Voloschin AD; Weinberg BD
    Acad Radiol; 2019 Jul; 26(7):974-980. PubMed ID: 30661977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using a Website to Teach a Structured Reporting System, the Brain Tumor Reporting and Data System.
    Kim S; Hoch MJ; Cooper ME; Gore A; Weinberg BD
    Curr Probl Diagn Radiol; 2021; 50(3):356-361. PubMed ID: 32081518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative Improvement in Brain Tumor MRI Through Structured Reporting (BT-RADS).
    Zhang JY; Weinberg BD; Hu R; Saindane A; Mullins M; Allen J; Hoch MJ
    Acad Radiol; 2020 Jun; 27(6):780-784. PubMed ID: 31471207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structured Reporting in Multiple Sclerosis - Consensus-Based Reporting Templates for Magnetic Resonance Imaging of the Brain and Spinal Cord.
    Riederer I; Mühlau M; Wiestler B; Bender B; Hempel JM; Kowarik M; Huber T; Zimmer C; Andrisan T; Patzig M; Zimmermann H; Havla J; Berlis A; Behrens L; Beer M; Dietrich J; Sollmann N; Kirschke JS
    Rofo; 2023 Feb; 195(2):135-138. PubMed ID: 35913055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Scalable Natural Language Processing for Inferring BT-RADS Categorization from Unstructured Brain Magnetic Resonance Reports.
    Lee SJ; Weinberg BD; Gore A; Banerjee I
    J Digit Imaging; 2020 Dec; 33(6):1393-1400. PubMed ID: 32495125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do patients with a PI-RADS 5 lesion identified on magnetic resonance imaging require systematic biopsy in addition to targeted biopsy?
    Drobish JN; Bevill MD; Tracy CR; Sexton SM; Rajput M; Metz CM; Gellhaus PT
    Urol Oncol; 2021 Apr; 39(4):235.e1-235.e4. PubMed ID: 33451935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adding DSC PWI and DWI to BT-RADS can help identify postoperative recurrence in patients with high-grade gliomas.
    Yang Y; Yang Y; Wu X; Pan Y; Zhou D; Zhang H; Chen Y; Zhao J; Mo Z; Huang B
    J Neurooncol; 2020 Jan; 146(2):363-371. PubMed ID: 31902040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer detection on transrectal ultrasonography-guided random biopsy despite negative real-time magnetic resonance imaging/ultrasonography fusion-guided targeted biopsy: reasons for targeted biopsy failure.
    Cash H; Günzel K; Maxeiner A; Stephan C; Fischer T; Durmus T; Miller K; Asbach P; Haas M; Kempkensteffen C
    BJU Int; 2016 Jul; 118(1):35-43. PubMed ID: 26384851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [PI-RADS classification: structured reporting for MRI of the prostate].
    Röthke M; Blondin D; Schlemmer HP; Franiel T
    Rofo; 2013 Mar; 185(3):253-61. PubMed ID: 23404430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of a Structured Reporting Template on Adherence to Prostate Imaging Reporting and Data System Version 2 and on the Diagnostic Performance of Prostate MRI for Clinically Significant Prostate Cancer.
    Shaish H; Feltus W; Steinman J; Hecht E; Wenske S; Ahmed F
    J Am Coll Radiol; 2018 May; 15(5):749-754. PubMed ID: 29506919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of Combined Magnetic Resonance Imaging/Ultrasound Fusion-guided and Systematic Biopsy of the Prostate in Biopsy-naïve Patients and Patients with Prior Biopsies.
    Preisser F; Theissen L; Wenzel M; Humke C; Bodelle B; Köllermann J; Kluth L; Banek S; Becker A; Roos F; Chun FK; Mandel P
    Eur Urol Focus; 2021 Jan; 7(1):39-46. PubMed ID: 31296485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osseous Tumor Reporting and Data System-Multireader Validation Study.
    Chhabra A; Gupta A; Thakur U; Pezeshk P; Dettori N; Callan A; Xi Y; Weatherall P
    J Comput Assist Tomogr; 2021 Jul-Aug 01; 45(4):571-585. PubMed ID: 34270485
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Humbert O; Bourg V; Mondot L; Gal J; Bondiau PY; Fontaine D; Saada-Bouzid E; Paquet M; Chardin D; Almairac F; Vandenbos F; Darcourt J
    Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):558-568. PubMed ID: 30612162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How does PI-RADS v2.1 impact patient classification? A head-to-head comparison between PI-RADS v2.0 and v2.1.
    Linhares Moreira AS; De Visschere P; Van Praet C; Villeirs G
    Acta Radiol; 2021 Jun; 62(6):839-847. PubMed ID: 32702998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.